Japan's Daiichi Sankyo and US drugmaker MSD have expanded their existing global co-development and co-commercialization agreement for three investigational DXd antibody drug conjugates to include MSD’s MK-6070, a compound MSD obtained through its recent acquisition of Harpoon Therapeutics.
AbbVie has completed its acquisition of Cerevel Therapeutics. According to AbbVie, Cerevel's pipeline is highly complementary to its own existing neuroscience portfolio. The takeover was announced in December 2023.
Carbios, a company specializing in biological technologies for the life cycle of plastic and textiles, and Sasa, a manufacturer of polyester and related products, have signed a Letter of Intent (LOI) to explore the potential acquisition of a license for Carbios’ PET biorecycling technology by Sasa.
Global specialty ingredients solution provider Barentz International recently announced the acquisition of Anshul Life Sciences in India, a specialty chemicals distributor that caters to regulated pharmaceuticals, food & nutraceuticals, and personal care markets.
French specialty materials manufacturer Arkema has opened its new technologies innovation lab for ultraviolet-light-cured (UV-cured), light emitting diode (LED-cured) and electron-beam-cured (EB-cured) curable resins and additives for specialty coating and adhesive applications at the company’s Kyoto Technical Center (KTC).
Clariant and OMV today announced their intended collaboration for lower carbon footprint ethylene supply. To address growing demand for sustainable options in Europe, this partnership will help both companies meet their sustainability targets and support their customers' carbon reduction strategies.
International Flavors & Fragrances (IFF) plans to complete the renovation and expansion of its facilities in Shanghai, China by the end of August. The 16,000 m2 site, named “Shanghai Creative Center,” is IFF’s largest in Asia.
GSK and innovation company Flagship Pioneering have entered a collaboration to develop a portfolio of new medicines and vaccines, starting in respiratory and immunology. Flagship’s ecosystem comprises 40 bioplatform companies, including Moderna.
CF Industries Holdings recently announced that it is moving forward with a carbon capture and sequestration (CCS) project at its Yazoo City, Mississippi, Complex that is expected to reduce the facility's carbon dioxide (CO2) emissions by up to 500,000 metric tons annually.
US biotechnology company Terremoto Biosciences has appointed Charles Baum CEO. He succeeds Peter Thompson, who will continue to serve as Terremoto’s board chairperson.
Malaysia's state energy firm Petronas, Italy's Enilive (a subsidiary of Eni), and Japanese company Euglena have reached the final investment decision (FID) to develop a biorefinery which will be located within Petronas’ Pengerang Integrated Complex (PIC) in Johor, Malaysia.
US biopharmaceutical company Dren Bio, a developer of novel antibody therapeutics, has entered into a collaboration with Novartis Pharma, a subsidiary of Novartis. The collaboration will focus on the discovery and development of therapeutic bispecific antibodies for cancer using Dren Bio’s proprietary targeted myeloid engager and phagocytosis platform.
Syensqo, a global provider of advanced materials, and Orbex, a leader in private space launch services, recently signed a strategic collaboration agreement to develop and deploy next-generation aerospace technologies.
Pfizer has commissioned its expanded, highly automated active pharmaceutical ingredient (API) manufacturing facility at the Tuas Biomedical Park in Singapore.
Yara, a global crop nutrition producer, and Atome, a developer of international green fertilizer projects, sign Heads of Terms for offtake from Atome’s renewable CAN project in Villeta, Paraguay.
Borouge, in a consortium with ADNOC and Borealis, and China’s Wanhua Chemical, together with Wanrong New Materials, a subsidiary controlled by Wanhua, signed a project collaboration agreement for a feasibility study to develop a 1.6 million t/y specialty state-of-the-art polyolefin complex in Fuzhou, Fujian Province, China.
Touchlight, a UK-based custom development and manufacturing organization (CDMO) specializing in enzymatic DNA production, signed a license agreement with British drugmaker GSK which grants GSK non-exclusive rights to use Touchlight’s proprietary enzymatic dbDNA (doggybone DNA) technology for the development and production of mRNA-based products.
Santa Clara, CA-based Agilent Technologies has signed a definitive agreement to acquire specialized contract development and manufacturing organization Biovectra from H.I.G. Capital in a move to expand its end-to-end biopharma solutions.
Integrals Power has started production of high-performance Lithium Iron Phosphate (LFP) and Lithium Manganese Iron Phosphate (LMFP) cathode active materials at its new UK pilot plant. This zero-emission power plant will help to accelerate development for the UK battery industry.
Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutical and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer.
The Nova Institute recently published a new report on alternative naphtha. The report analyzes the routes, associated technologies, market players, and volumes by which renewable carbon can be introduced to refinery and steam cracking operations to replace fossil-based feedstocks.
CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform.
Ar-ena is a female-led start-up from Jordan, that produces a new type of hydrogel-polymers that absorb air humidity and convert it into water.
Evonik has announced the expansion of its sodium methylate production capacity at its Rosario plant in Argentina. The company's expansion contributes to its ongoing role in the biofuels industry and supports its efforts in innovation and sustainability in South America.
Honeywell and Air Products recently announced that Honeywell has agreed to acquire Air Products’ liquefied natural gas (LNG) process technology and equipment business for €1.67 billion ($1.81 billion) in an all-cash transaction. This represents approximately 13x the estimated 2024 EBITDA.
Syensqo has completed the acquisition of a controlling stake in Azerys, a specialist in rosemary extraction with assets in El Jadida, Morocco.
A newly updated and automated production line is operational at AkzoNobel’s Suzhou site in China. The improvements are part of a €14 million investment to accelerate growth and double the plant’s marine and protective coatings capacity by 2025.
German chemicals, pharmaceuticals and life sciences group Merck entered a non-binding Memorandum of Understanding (MoU) with Afrigen Biologics to support the development of an mRNA vaccine technology platform. The collaboration is aimed at advancing mRNA platform manufacturing capabilities, scaling up production, optimizing processes, and providing troubleshooting expertise, the companies said.
Belgium-headquartered specialty materials producer Syensqo and Allozymes, a Singaporean enzyme engineering start-up, have signing of a Memorandum of Understanding (MoU) to leverage both companies’ expertise in biotechnology to develop advanced biosolutions for home and personal care, particularly for the skin care market.
Italian engineering group Maire Tecnimont announced that its subsidiary NextChem, which specializes in sustainable technology solutions, has been awarded a feasibility study and a pre-FEED (front-end engineering design) contract by FertigHy to use NX Stami Green Ammonia and NX Stami Nitric Acid technologies.
Navin Molecular, an Indian-headquartered CDMO with small molecule development and manufacturing capabilities, recently announced a Rs 288 Crore (approximately €32.6 million/$35 million) investment to construct a 9,000 m2 GMP manufacturing plant in Dewas, India. The new facility will nearly double the overall capacity at the site to 420 m3. It will support existing commercial-scale projects and meet future demands as the company continues to expand its global customer base.
In a move to enter the activated carbon market for micropollutants removal, Finnish chemicals company Kemira has agreed to purchase Norit’s UK reactivation business from Purton Carbons. The deal is expected to close in the third quarter of2024. Financial details of the deal were not disclosed.
South Korea-headquartered contract development and manufacturing organization (CDMO) SK Bioscience plans to acquire a 60% stake in IDT Biologika, a German CDMO specialized in vaccines, gene and immune therapy and oncolytic viruses, from Klocke Group. Klocke will retain a 40% stake in IDT Biologika and thus remains the company's second-largest shareholder.
AbbVie has acquired Celsius Therapeutics, a privately held biotechnology company developing new therapies inflammatory diseases, for $250 million in cash. The transaction is subject to certain customary adjustments.
Specialty material solutions provider Trinseo recently announced the opening of its polymethyl methacrylate (PMMA) depolymerization facility in Rho, Italy. The pilot facility demonstrates the company’s commitment to sustainability by advancing next-generation recycling technology for acrylic solutions, in line with Trinseo’s 2030 Sustainable Product Portfolio Goals.
